SCYNEXIS, Inc. Stock Issued During Period, Shares, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- SCYNEXIS, Inc. stock issued during period, shares, new issues for the quarter ending 2015-12-31 was 0.00 shares.
- SCYNEXIS, Inc. stock issued during period, shares, new issues for the quarter ending 2015-09-30 was 0.00 shares.
- SCYNEXIS, Inc. stock issued during period, shares, new issues for the quarter ending 2014-12-31 was 0.00 shares.
- SCYNEXIS, Inc. stock issued during period, shares, new issues for the quarter ending 2014-09-30 was 0.00 shares.
- SCYNEXIS, Inc. stock issued during period, shares, new issues for fiscal 2016 was 10.70M shares, a 98.94% increase from fiscal 2015.
- SCYNEXIS, Inc. stock issued during period, shares, new issues for fiscal 2015 was 5.38M shares, a 13.28% decline from fiscal 2014.
- SCYNEXIS, Inc. stock issued during period, shares, new issues for fiscal 2014 was 6.20M shares.
| Period end | Stock Issued During Period, Shares, New Issues 3 month | Stock Issued During Period, Shares, New Issues 12 month |
|---|---|---|
| 2016-12-31 | 10.70M shares 10-K · filed 2017-03-13 | |
| 2015-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | 5.38M shares 10-K · filed 2017-03-13 |
| 2015-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | |
| 2014-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-07 | 6.20M shares 10-K · filed 2016-03-07 |
| 2014-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |